Published in Microb Pathog on October 01, 2002
FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol (2010) 2.44
FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med (2004) 1.95
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc Natl Acad Sci U S A (2011) 1.24
Fcgamma receptor regulation of Citrobacter rodentium infection. Infect Immun (2008) 0.90
Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival. Transplantation (2014) 0.83
Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB. J Immunol Res (2015) 0.76
Fcγ Receptors in Solid Organ Transplantation. Curr Transplant Rep (2016) 0.75
Resistin, an adipokine with potent proinflammatory properties. J Immunol (2005) 3.63
The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe (2007) 2.27
Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol (2004) 2.17
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum (2003) 1.93
Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol (2006) 1.86
Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol (2004) 1.80
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum (2003) 1.65
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging (2002) 1.56
Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 1.51
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest (2007) 1.47
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther (2005) 1.43
Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One (2006) 1.38
Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J Bacteriol (2007) 1.34
Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur J Immunol (2003) 1.32
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.26
Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum (2006) 1.24
The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One (2009) 1.19
Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One (2008) 1.19
Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci U S A (2006) 1.18
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Expression of FcgammaRIII is required for development of collagen-induced arthritis. Eur J Immunol (2002) 1.14
Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol (2002) 1.09
Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol (2005) 1.08
Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther (2008) 1.08
Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol (2008) 1.05
Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther (2005) 1.05
Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun (2007) 1.04
Tissue factor as a proinflammatory agent. Arthritis Res (2002) 1.04
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
Phenotypic and functional characterization of human CD25+ B cells. Immunology (2006) 1.02
Arthritogenic properties of double-stranded (viral) RNA. J Immunol (2004) 1.01
Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus. Microbes Infect (2012) 0.99
Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome. J Immunol (2012) 0.99
Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol (2003) 0.99
Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb. Clin Immunol (2008) 0.99
Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 0.97
Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis. FASEB J (2008) 0.96
T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect (2004) 0.96
Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta (2009) 0.95
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther (2009) 0.93
High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis. Arthritis Res Ther (2007) 0.93
Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis. PLoS One (2008) 0.92
Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res Ther (2009) 0.91
Survivin is an essential mediator of arthritis interacting with urokinase signalling. J Cell Mol Med (2009) 0.91
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol (2007) 0.91
Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect (2004) 0.90
Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis. Ann Med (2010) 0.89
Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr Opin Rheumatol (2004) 0.88
The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res (2008) 0.86
Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis. Arthritis Rheum (2009) 0.86
Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis. Cell Mol Immunol (2011) 0.86
Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. J Leukoc Biol (2007) 0.86
Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J Rheumatol (2003) 0.86
Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol (2005) 0.85
Anti-staphylococcal activities of lysostaphin and LytM catalytic domain. BMC Microbiol (2012) 0.85
Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis Res Ther (2002) 0.84
Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol (2013) 0.84
Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course. Eur J Immunol (2008) 0.84
Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect (2004) 0.84
In vivo sortase A and clumping factor A mRNA expression during Staphylococcus aureus infection. Microb Pathog (2007) 0.84
Salivary resistin reflects local inflammation in Sjögren's syndrome. J Rheumatol (2008) 0.83
Human alpha -defensins neutralize fibrinolytic activity exerted by staphylokinase. Thromb Haemost (2004) 0.83
The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J Clin Periodontol (2002) 0.83
Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis. Clin Immunol (2010) 0.83
Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis (2010) 0.82
mgrA regulates staphylococcal virulence important for induction and progression of septic arthritis and sepsis. Microbes Infect (2008) 0.82
IgG Fc receptor polymorphisms and association with autoimmune disease. Eur J Immunol (2005) 0.82
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther (2004) 0.82
Inflammatogenic properties of bacterial DNA following cutaneous exposure. J Invest Dermatol (2003) 0.82
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Res Ther (2004) 0.82
Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum (2006) 0.82
Rapid systemic bone resorption during the course of Staphylococcus aureus-induced arthritis. J Infect Dis (2006) 0.81
Staphylokinase reduces plasmin formation by endogenous plasminogen activators. Eur J Haematol (2008) 0.81
Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol (2004) 0.81
T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice. Arthritis Rheum (2011) 0.81
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes Infect (2006) 0.81
Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades. J Leukoc Biol (2008) 0.81
Formylated peptides are important virulence factors in Staphylococcus aureus arthritis in mice. J Infect Dis (2011) 0.81
The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs. Inflammation (2004) 0.80
Urokinase-type plasminogen activator, an endogenous antibiotic. J Infect Dis (2005) 0.80
Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol (2005) 0.80
Enhanced susceptibility to low-dose collagen-induced arthritis in CR1/2-deficient female mice--possible role of estrogen on CR1 expression. FASEB J (2009) 0.80
Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock. Infect Immun (2002) 0.80
Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res (2007) 0.80
RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone (2009) 0.79
The effect of activating and inhibiting Fc-receptors on murine mercury-induced autoimmunity. J Autoimmun (2008) 0.79
The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus. Int Immunopharmacol (2004) 0.79
Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling. Arthritis Res Ther (2008) 0.79
Identification of conserved antigens from staphylococcal and streptococcal pathogens. J Med Microbiol (2012) 0.78
Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis. Arthritis Res Ther (2005) 0.78
Immunostimulatory DNA induces degranulation and NADPH-oxidase activation in human neutrophils while concomitantly inhibiting chemotaxis and phagocytosis. Eur J Immunol (2002) 0.78
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford) (2009) 0.77
The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis. Microbes Infect (2004) 0.77
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2009) 0.76
Up regulated complement and fc receptors in juvenile idiopathic arthritis and correlation with disease phenotype. J Clin Immunol (2012) 0.76
Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies. FEMS Immunol Med Microbiol (2008) 0.76
Molecular basis for T cell response induced by altered peptide ligand of type II collagen. J Biol Chem (2012) 0.76
Synergistic action of immunostimulatory DNA and fcgamma receptor IIB-crosslinking on B-cell phenotype and function. Immunobiology (2005) 0.75